Lam Research Corporation $LRCX Shares Sold by Formuepleje A S

Key Points

• Formuepleje A S reduced its Lam Research stake by 51.6% in the second quarter, selling 8,075 shares and retaining 7,565 shares valued at approximately $3.28 million. Institutional investors still own 84.61% of the company.
• Lam Research reported strong quarterly results, with revenue rising 30% year over year to $6.72 billion and EPS of $1.82, beating analysts’ expectations. The company also raised its quarterly dividend by about 27% to $0.33 per share.
• Insiders sold 77,782 shares worth approximately $26.8 million over the past 90 days, while analysts maintain a “Moderate Buy” consensus with an average price target of $358.97.

Formuepleje A S lessened its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 51.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,565 shares of the semiconductor company's stock after selling 8,075 shares during the quarter. Formuepleje A S's holdings in Lam Research were worth $3,278,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Bayban bought a new stake in Lam Research in the fourth quarter valued at about $26,000. Vermillion Wealth Management Inc. acquired a new position in shares of Lam Research in the 1st quarter worth approximately $26,000. Cedar Mountain Advisors LLC increased its holdings in shares of Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after acquiring an additional 85 shares during the last quarter. Paladin Partners LLC acquired a new stake in shares of Lam Research during the 2nd quarter valued at approximately $26,000. Finally, Mcguire Capital Advisors Inc. bought a new position in Lam Research during the fourth quarter worth $27,000. Institutional investors own 84.61% of the company's stock.

Insider Activity

In related news, Director Eric Brandt sold 54,500 shares of the stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the firm's stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. The trade was a 17.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 77,782 shares of company stock valued at $26,755,370. Company insiders own 0.31% of the company's stock.

Lam Research Stock Performance

Shares of NASDAQ LRCX opened at $307.65 on Monday. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The stock has a 50 day simple moving average of $321.34 and a 200-day simple moving average of $291.79. The company has a market cap of $384.97 billion, a PE ratio of 53.41, a P/E/G ratio of 1.22 and a beta of 1.85. Lam Research Corporation has a 12-month low of $100.68 and a 12-month high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business's revenue for the quarter was up 30.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, equities research analysts forecast that Lam Research Corporation will post 9.33 EPS for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be paid a $0.33 dividend. The ex-dividend date of this dividend is Wednesday, September 23rd. This is a positive change from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. Lam Research's dividend payout ratio (DPR) is currently 18.06%.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $320.00 target price on shares of Lam Research in a research note on Thursday, July 30th. Sanford C. Bernstein increased their price objective on shares of Lam Research from $325.00 to $340.00 and gave the stock an "outperform" rating in a research note on Thursday, May 21st. Wall Street Zen cut shares of Lam Research from a "buy" rating to a "hold" rating in a report on Sunday, May 10th. Zacks Research upgraded Lam Research from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 17th. Finally, Jefferies Financial Group set a $335.00 target price on Lam Research and gave the company a "buy" rating in a report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $358.97.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
• Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
• Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
• Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
• Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
• Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
• Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.